HomeProductsDexchlorpheniramine
Chemical structure of CAS 25523-97-1

Dexchlorpheniramine

CAS No.25523-97-1
MDL No.N/A
MFC16H19ClN2
MW274.79
InChI KeySOYKEARSMXGVTM-HNNXBMFYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Dexchlorpheniramine is a chlorphenamine and the enantiomer of levochlorpheniramine.

CAS No.25523-97-1
Product NameDexchlorpheniramine

Biological Targets

HRH1

Associated Conditions

urticaria·allergic disease·allergic conjunctivitis·Rhinitis, Allergic, Perennial·allergic rhinitis·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Histamine regulation of interleukin-18-initiating cytokine cascade is associated with down-regulation of intercellular adhesion molecule-1 expression in human peripheral blood mononuclear cells.

The Journal of pharmacology and experimental therapeutics • Vol. 300, Issue 1 • 2002
PMID: 11752121DOI: 10.1124/jpet.300.1.227

Possible involvement of tachykinin NK(1) and NMDA receptors in histamine-induced hyperalgesia in mice.

European journal of pharmacology • Vol. 434, Issue 1-2 • 2002
PMID: 11755162DOI: 10.1016/s0014-2999(01)01523-0

Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration.

British journal of clinical pharmacology • Vol. 53, Issue 3 • 2002
PMID: 11874393PMC: PMC1874306DOI: 10.1046/j.0306-5251.2001.01183.x

Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 19, Issue 5 • 2001
PMID: 11230474DOI: 10.1200/JCO.2001.19.5.1320

Documentation

Similar Products